Noonan syndrome gene

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) C12Q 1/42 (2006.01) C12N 9/16 (2006.01) C12N 15/55 (2006.01)

Patent

CA 2495529

Diagnostic and therapeutic applications for Noonan Syndrome are described. The diagnostic and therapeutic applications are based on certain mutations in the protein tyrosine phosphatase gene PTPN11 and its expression product, PTPN11. Also described are nucleotide sequences, amino acid sequences, probes, and primers related to PTPN11 and PTP11 variants, and cells expressing such variants.

L'invention concerne des applications diagnostiques et thérapeutiques visant le syndrome de Noonan. Les applications diagnostiques et thérapeutiques sont basées sur certaines mutations dans le gène des protéines tyrosine phosphatase <i>PTPN11</i> et sur son produit d'expression <i>PTPN11</i>. L'invention décrit aussi des séquences nucléotidiques, des séquences d'acides amines, des sondes et des amorces liées à <i>PTPN11</i> et aux variants de <i>PTP11</i> ainsi que des cellules exprimant ces variants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Noonan syndrome gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Noonan syndrome gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Noonan syndrome gene will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1723042

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.